triumph 1 retatrutide A summary slide of the TRIUMPH-1 data presented today by Dr. Ania Jastreboff at #ADA2026 π¨ TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide π¨ Retatrutide π, a once-weekly triple hormone receptor TRIUMPH-1: Retatrutide Substantially Lowers Weight,
Description
Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks
Discover how protein helps preserve muscle and keep you full.
Excluding GLP-1, pharma IRR drops from 5.9% to 3.8%
Cheapest GLP-1 without insurance 2026: Ozempic, Wegovy, Mounjaro, Zepbound price comparison
Best prices in Japan
Smith N, Atroch AL
